Clinical trials
Completed Observational Cholecystitis, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2011 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital del Mar | 4 |
| Peking Union Medical College Hospital | 2 |
| Asklepios Klinik Langen | 1 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| Bakirkoy Dr. Sadi Konuk Research and Training Hospital | 1 |
| Catholic University of the Sacred Heart | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Cheju Halla General Hospital | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholecystitis, Acute | 35 |
| Appendicitis | 2 |
| Cholecystitis | 2 |
| Gallbladder Diseases | 2 |
| Abdominal Pain | 1 |
| Acute Pain | 1 |
| Aortic Aneurysm, Abdominal | 1 |
| Bile Duct Diseases | 1 |
| Biliary Tract Diseases | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.